Literature DB >> 8017066

[Possibilities and limits of CO2 balneotherapy].

K L Resch1, U Just.   

Abstract

CO2 baths are considered an integral feature of balneotherapy. Natural springs containing a concentration of CO2 probably sufficient to be clinically effective (> 1 g/l) as well as artificially enriched baths are applied. Phenomena like a marked erythema (at concentrations above 0.5 g/l) imply clinical efficacy beyond unspecific effects of baths (water immersion, thermal effects). Prolonged effects are postulated to exceed "direct" effects, thus forming the rationale for serial applications of CO2-baths. CO2 is believed to cause an acute induction of local vasodilation and a shift of the O2 binding curve, resulting in a facilitation of the delivery of O2 to the tissue. A positive impact of CO2-baths on the flow properties of blood has been reported. A wide variety of indications is mentioned in the literature, while clear evidence from controlled trials exists only for a minority of them, mainly for chronic circulatory disturbances based on atherosclerotic diseases such as peripheral arterial occlusive disease, trophic ulceration, microangiopathies of various origins, and mild hypertension. Some evidence supports the idea that CO2 baths might represent an efficient therapeutic means in the rehabilitation of coronary heart disease, myocardial infarction and stroke, and in the treatment of chronic venous insufficiency, certain inflammatory diseases, and functional disturbances.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8017066

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  5 in total

Review 1.  Head-out immersion in natural thermal mineral water for the management of hypertension: a review of randomized controlled trials.

Authors:  Dan Yuan; Zhao-Xia Yu; Wen Wang; Yu Chen
Journal:  Int J Biometeorol       Date:  2019-08-11       Impact factor: 3.787

2.  Transcutaneous application of carbon dioxide (CO2) induces mitochondrial apoptosis in human malignant fibrous histiocytoma in vivo.

Authors:  Yasuo Onishi; Teruya Kawamoto; Takeshi Ueha; Kenta Kishimoto; Hitomi Hara; Naomasa Fukase; Mitsunori Toda; Risa Harada; Masaya Minoda; Yoshitada Sakai; Masahiko Miwa; Masahiro Kurosaka; Toshihiro Akisue
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

3.  Transcutaneous carbon dioxide induces mitochondrial apoptosis and suppresses metastasis of oral squamous cell carcinoma in vivo.

Authors:  Daisuke Takeda; Takumi Hasegawa; Takeshi Ueha; Yusuke Imai; Akiko Sakakibara; Masaya Minoda; Teruya Kawamoto; Tsutomu Minamikawa; Yasuyuki Shibuya; Toshihiro Akisue; Yoshitada Sakai; Masahiro Kurosaka; Takahide Komori
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

4.  Transcutaneous Carbon Dioxide Decreases Immunosuppressive Factors in Squamous Cell Carcinoma In Vivo.

Authors:  Nanae Yatagai; Takumi Hasegawa; Rika Amano; Izumi Saito; Satomi Arimoto; Daisuke Takeda; Yasumasa Kakei; Masaya Akashi
Journal:  Biomed Res Int       Date:  2021-07-02       Impact factor: 3.411

5.  Percutaneous CO2 Treatment Accelerates Bone Generation During Distraction Osteogenesis in Rabbits.

Authors:  Yohei Kumabe; Tomoaki Fukui; Shunsuke Takahara; Yu Kuroiwa; Michio Arakura; Keisuke Oe; Takahiro Oda; Kenichi Sawauchi; Takehiko Matsushita; Tomoyuki Matsumoto; Shinya Hayashi; Ryosuke Kuroda; Takahiro Niikura
Journal:  Clin Orthop Relat Res       Date:  2020-08       Impact factor: 4.755

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.